Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | -.--% | -.--% | -34.46% |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Shawah
FOU | Founder | 57 | 17-06-30 |
David Luci
CEO | Chief Executive Officer | 57 | 17-06-30 |
Chief Tech/Sci/R&D Officer | - | - | |
Lisa Wilson
IRC | Investor Relations Contact | - | - |
Mintz Levin
LAW | General Counsel | - | - |
Larry Mortin
PRN | Corporate Officer/Principal | - | - |
Xiang Yu
PRN | Corporate Officer/Principal | - | - |
Les Johnson
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert de Luccia
FOU | Founder | 78 | 17-06-30 |
Joseph Scodari
BRD | Director/Board Member | 71 | 21-06-23 |
Thomas Harrison
BRD | Director/Board Member | 76 | 21-06-23 |
David Luci
CEO | Chief Executive Officer | 57 | 17-06-30 |
Carl Sailer
BRD | Director/Board Member | 54 | 18-10-22 |
Jack Dean
BRD | Director/Board Member | 82 | 21-06-23 |
James Donohue
BRD | Director/Board Member | 54 | 21-06-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,843,102 | 13,438,479 ( 84.82 %) | 0 | 84.82 % |
Company contact information
Acurx Pharmaceuticals, Inc.
259 Liberty Avenue Staten Island
10305, New York
+917 533 1469
http://www.acurxpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.46% | 39.72M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- ACXP Stock
- Company Acurx Pharmaceuticals, Inc.